ecqm.dataelement

Aromatase Inhibitors Active

Description:

Clinical Focus: This value set identifies patients who were prescribed a aromatase inhibitor.

Data Element Scope: This value set was intended to map to the QDM data type of Medication, but has the potential to be used in additional ways.

Inclusion Criteria: Includes both steroidal and non-steroidal inhibitors. Includes non-selective and selective inhibitors.

Exclusion Criteria: Excludes selective inhibitors vorozole, formestane, and fadrozole.

Subject constrained to the Aromatase Inhibitors

QDM Datatype: MedicationActive

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set is being taken by the patient. Keep in mind that when this datatype is used with timing relationships, the criterion is looking for a medication being taken for the time frame indicated by the timing relationships. Timing: The Relevant Period addresses: StartTime = when the medication is first known to be used (generally the time of entry on the medication list); StopTime = when the medication is discontinued (generally, the time discontinuation is recorded on the medication list)

Used By:

• CMS249v1

Included in Unions:

• IndependentRiskFactorsBeforeMeasurementPeriodUnion

QDM Attributes

Subject.Statement

Defined in Activity

DataType

Constrained in AromataseInhibitorsActive

AromataseInhibitors

RelevantPeriod

Relevant Period addresses the time between the start of an action to the end of an action. Each datatype using relevant period defines specific definitions for the start and stop time for the action listed.

Dosage

Details of how medication is taken or is to be taken, i.e., the quantity (mg, cc, tablets) to be taken at a single administration.

Supply

The quantity (amount) of therapeutic agent that was provided to a patient (i.e., number of doses, number of tablets or pills, volume of medication). Indicated to be given during a procedure, diagnostic test, or medication or substance administration. Note: Prior versions of the QDM (4.3 and earlier) addressed “dose” with two potential interpretations – (1) the quantity to be taken or administered with each administration and (2) the quantity of medication supplied (i.e., number of doses). QDM 5.0 and subsequent versions clarify the difference by defining “dosage” and “supply,” respectively. Note: Medication, Discharge includes medications the provider has indicated the patient should take after dischange from the hospital. This medication list is part of the discharge instructions provided to a patient. The list may include medication supply if it incorporates medication orders written at discharge even though the supply will not be present for medications the patient already has at home or purchases over- the-counter (without a prescription).

Frequency

Indicates how frequently the medication or substance, Is administered to a patient for an active medication (a), Was administered to the patient (b), Should be taken by the patient or administered to the patient (c), Is recommended to be given to the patient (d).

Route

Refers to the path by which the medication or substance should be taken into the body systems, such as intradermally, intrathecally, intramuscularly, intranasally, intravenously, orally, rectally, subcutaneously, sublingually, topically, or vaginally.